glp-1 semaglutide How medications are transforming diabetes and weight loss treatment GLP-1 Drugs from the Gray

At higher doses, it may be harder to tolerate, but we wont fully understand its long-term safety risks until we have more data

Clinical studies show tirzepatide provides superior A1C reduction (up to 2.4% decrease) and weight loss compared to semaglutide, but requires careful monitoring for hypoglycemia, especially in patients on insulin or sulfonylureas

Shed tirzepatide side effects and safety Tirzepatide side effects are real

What to expect: The focus shifts from rapid weight loss to sustainable progress

Integrating these perspectives provides a coherent foundation for anticipating variability in treatment responses and for informing the clinical management strategies outlined in the following chapters